AdventHealth Orlando — Orlando, Florida

Public research footprint of AdventHealth Orlando, compiled from the ClinicalTrials.gov public registry.

384

Registered studies

197

Active

Recruiting now

149

Completed

Stopped or withdrawn

Most-studied conditions

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage II Esophageal Adenocarcinoma AJCC v8 · Myelodysplastic Syndrome With Excess Blasts-1 · Resectable Pancreatic Acinar Cell Carcinoma

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT04320888 — Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at AdventHealth Orlando?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.